These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31136984)

  • 1. RICH2, a potential tumor suppressor in hepatocellular carcinoma.
    Zhang J; Yang C; Gong L; Zhu S; Tian J; Zhang F; Zhu Q; Wang J; Lan M; Li Y; Zhang W
    Front Biosci (Landmark Ed); 2019 Jun; 24(8):1363-1376. PubMed ID: 31136984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma.
    Wu HT; Xie CR; Lv J; Qi HQ; Wang F; Zhang S; Fang QL; Wang FQ; Lu YY; Yin ZY
    Lab Invest; 2018 Aug; 98(8):1014-1024. PubMed ID: 29785050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis.
    Qu D; Cui F; Lu D; Yang Y; Xu Y
    Cancer Sci; 2019 Jan; 110(1):157-165. PubMed ID: 30417471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
    Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
    Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.
    Zhang JG; Shi Y; Hong DF; Song M; Huang D; Wang CY; Zhao G
    Sci Rep; 2015 Jan; 5():8087. PubMed ID: 25627001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.
    Yang W; Wang B; Yu Q; Liu T; Li T; Tian T; Jin A; Ding L; Chen W; Wang H; Xian J; Pan B; Zhou J; Fan J; Yang X; Guo W
    Theranostics; 2022; 12(14):6189-6206. PubMed ID: 36168627
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
    Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
    Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma.
    Li A; Yan Q; Zhao X; Zhong J; Yang H; Feng Z; Du Y; Wang Y; Wang Z; Wang H; Zhou Y; Liu S; Nie Y
    Oncotarget; 2016 Jan; 7(1):524-37. PubMed ID: 26594798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3.
    Liu K; Li X; Cao Y; Ge Y; Wang J; Shi B
    Int J Oncol; 2015 Oct; 47(4):1585-93. PubMed ID: 26252738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 17. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z; Zhang Y; Xu Z
    J BUON; 2018; 23(1):188-192. PubMed ID: 29552782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.
    Zhou X; Zhang CZ; Lu SX; Chen GG; Li LZ; Liu LL; Yi C; Fu J; Hu W; Wen JM; Yun JP
    Oncogene; 2015 Feb; 34(8):965-77. PubMed ID: 24632613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior.
    Cheng X; Wu H; Jin ZJ; Ma D; Yuen S; Jing XQ; Shi MM; Shen BY; Peng CH; Zhao R; Qiu WH
    Sci Rep; 2017 Sep; 7(1):12362. PubMed ID: 28959024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.